IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 6.78
-0.10 (-1.45%)
May 6, 2026, 2:56 PM GMT
IXICO Employees
IXICO had 79 employees as of September 30, 2025. The number of employees decreased by 2 or -2.47% compared to the previous year.
Employees
79
Change (1Y)
-2
Growth (1Y)
-2.47%
Revenue / Employee
82.71K GBP
Profits / Employee
-20.90K GBP
Market Cap
14.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 79 | -2 | -2.47% |
| Sep 30, 2024 | 81 | -8 | -8.99% |
| Sep 30, 2023 | 89 | -1 | -1.11% |
| Sep 30, 2022 | 90 | -3 | -3.23% |
| Sep 30, 2021 | 93 | 11 | 13.41% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Arecor Therapeutics | 44 |
| SkinBioTherapeutics | 41 |
| Oxford BioDynamics | 41 |
| Aptamer Group | 30 |
| Fusion Antibodies | 24 |
| Poolbeg Pharma | 16 |
| ImmuPharma | 6 |
| Genflow Biosciences | 5 |